11C-DPA-713: A Novel Peripheral Benzodiazepine Receptor PET Ligand for In Vivo Imaging of Neuroinflammation
暂无分享,去创建一个
Philippe Hantraye | Bertrand Tavitian | Michael Kassiou | Fabien Chauveau | Michelle L. James | R. Trébossen | M. Grégoire | B. Tavitian | M. James | M. Kassiou | F. Dollé | P. Hantraye | H. Boutin | F. Chauveau | C. Thominiaux | Hervé Boutin | Cyrille Thominiaux | Marie-Claude Grégoire | Régine Trebossen | Frédéric Dollé | Cyrille Thominiaux
[1] R. Tanzi,et al. The genetic epidemiology of neurodegenerative disease. , 2005, The Journal of clinical investigation.
[2] Roger N Gunn,et al. In-vivo measurement of activated microglia in dementia , 2001, The Lancet.
[3] F. Turkheimer,et al. Towards a transcriptome definition of microglial cells , 2004, Neurogenetics.
[4] N L Foster,et al. PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] C. Wiessner,et al. Time course of microglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in mice , 1998, Acta Neuropathologica.
[6] G. Fur,et al. Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization , 1983, Journal of neurochemistry.
[7] Alexander Hammers,et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease , 2006, Neurobiology of Disease.
[8] Yuji Nagai,et al. Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: An imaging tool for glial cells in the brain , 2004, Synapse.
[9] R B Banati,et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. , 2000, Brain : a journal of neurology.
[10] Hyun B Choi,et al. Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum , 2005, Neurobiology of Disease.
[11] Alan C. Evans,et al. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis , 1997, Journal of neuroscience research.
[12] B. Kiss,et al. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects , 2002, Acta neurologica Scandinavica.
[13] Ryuji Nakao,et al. Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] A. Biegon,et al. Region‐selective effects of neuroinflammation and antioxidant treatment on peripheral benzodiazepine receptors and NMDA receptors in the rat brain , 2002, Journal of neurochemistry.
[15] D. Graham,et al. Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. , 1987, Journal of neurology, neurosurgery, and psychiatry.
[16] E. Yoshikawa,et al. Microglial activation and dopamine terminal loss in early Parkinson's disease , 2005, Annals of neurology.
[17] F. Fazio,et al. Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration , 2004, Neurochemistry International.
[18] C. Mathers,et al. Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.
[19] B. Gulyás,et al. [11C]Vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies , 2005, Journal of the Neurological Sciences.
[20] N. Rothwell,et al. Sixteenth Gaddum Memorial Lecture December 1996. Neuroimmune interactions: the role of cytokines , 1997, British journal of pharmacology.
[21] Tetsuya Suhara,et al. Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain. , 2004, Journal of medicinal chemistry.
[22] Ronald Boellaard,et al. Development of a Tracer Kinetic Plasma Input Model for (R)-[11C]PK11195 Brain Studies , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[23] S. Meikle,et al. Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand. , 2005, Bioorganic & medicinal chemistry.
[24] K. Hossmann,et al. Monitoring the temporal and spatial activation pattern of astrocytes in focal cerebral ischemia using in situ hybridization to GFAP mRNA: comparison withsgp-2 andhsp70 mRNA and the effect of glutamate receptor antagonists , 1996, Brain Research.
[25] R. Dempsey,et al. Up‐regulation of the peripheral‐type benzodiazepine receptor expression and [3H]PK11195 binding in gerbil hippocampus after transient forebrain ischemia , 2001, Journal of neuroscience research.
[26] A. Gee,et al. The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker. , 2003, Nuclear medicine and biology.
[27] D. Schober,et al. Peripheral benzodiazepine receptors are colocalized with activated microglia following transient global forebrain ischemia in the rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[28] Jean-Claude Baron,et al. In Vivo Mapping of Brain Benzodiazepine Receptor Changes by Positron Emission Tomography After Focal Ischemia in the Anesthetized Baboon , 1993, Stroke.
[29] R B Banati,et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 , 2000, Neurology.
[30] S. Kohsaka,et al. Microglia: neuroprotective and neurotrophic cells in the central nervous system. , 2004, Current drug targets. Cardiovascular & haematological disorders.
[31] Tetsuya Suhara,et al. [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. , 2003, Nuclear medicine and biology.
[32] C. Martini,et al. 2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides. New potent and selective peripheral benzodiazepine receptor ligands. , 2001, Bioorganic & medicinal chemistry.
[33] M. Grégoire,et al. Improved synthesis of the peripheral benzodiazepine receptor ligand [11C]DPA-713 using [11C]methyl triflate. , 2006, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[34] David K. Menon,et al. Intrinsic Activated Microglia Map to the Peri-infarct Zone in the Subacute Phase of Ischemic Stroke , 2006, Stroke.
[35] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[36] J. Bénavidès,et al. In vivo labelling in several rat tissues of 'peripheral type' benzodiazepine binding sites. , 1984, European journal of pharmacology.
[37] F. Turkheimer,et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study , 2004, Neurobiology of Disease.
[38] J C Baron,et al. Brain kinetics and specific binding of [11C]PK 11195 to omega 3 sites in baboons: positron emission tomography study. , 1991, European journal of pharmacology.
[39] André Syrota,et al. Synthesis of N‐(11C) methyl, N‐(methyl‐1 propyl), (chloro‐2 phenyl)‐1 isoquinoleine carboxamide‐3 (PK 11195): A new ligand for peripheral benzodiazepine receptors , 1984 .
[40] R Myers,et al. The distribution of radioactivity in brains of rats given [N-methyl-11C]PK 11195 in vivo after induction of a cortical ischaemic lesion. , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.